Cooper Companies (COO) Research & Development (2009 - 2026)
Cooper Companies' (COO) quarterly Research & Development came in at $42.5 million in Q2 2026, down 6.59% year-on-year from $45.5 million in Q2 2025, and down 4.06% quarter-over-quarter from $44.3 million in Q1 2026.
Cooper Companies (COO) Research & Development (2009 - 2026) Analysis & Trends
Cooper Companies' Research & Development history runs 18 years deep, the most recent figure standing at $42.5 million for Q2 2026.
- On a quarterly basis, Research & Development fell 6.59% year-over-year to $42.5 million in Q2 2026; TTM through Apr 2026 was $172.8 million, a 6.08% increase from a year earlier, with the FY2025 full-year figure at $172.2 million, up 11.03% from the prior year.
- Research & Development slipped to $42.5 million in Q2 2026 per COO's latest filing, from $44.3 million in the prior quarter.
- Across five years, Research & Development topped out at $45.5 million in Q2 2025 and bottomed at $26.2 million in Q1 2022.
- The 5-year median for Research & Development is $38.3 million (2024), against an average of $36.8 million.
- Across the five-year window, Research & Development gained 27.18% in 2023 and declined 6.59% in 2026, its largest moves.
- Year by year, Research & Development stood at $29.1 million in 2022, then climbed by 26.12% to $36.7 million in 2023, then grew by 2.72% to $37.7 million in 2024, then climbed by 9.81% to $41.4 million in 2025, then grew by 2.66% to $42.5 million in 2026.
- Per Business Quant, the three latest COO Research & Development figures stand at $42.5 million (Q2 2026), $44.3 million (Q1 2026), and $41.4 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -245.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 370.60 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 249.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 94.27 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 19.70 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 42.50 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 189.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 98.66 Mn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | 139.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 42.50 Mn |
| Jan 31, 2026 | 44.30 Mn |
| Oct 31, 2025 | 41.40 Mn |
| Jul 31, 2025 | 44.60 Mn |
| Apr 30, 2025 | 45.50 Mn |
| Jan 31, 2025 | 40.70 Mn |
| Oct 31, 2024 | 37.70 Mn |
| Jul 31, 2024 | 39.00 Mn |
| Apr 30, 2024 | 38.90 Mn |
| Jan 31, 2024 | 39.50 Mn |
| Oct 31, 2023 | 36.70 Mn |
| Jul 31, 2023 | 36.50 Mn |
| Apr 30, 2023 | 32.60 Mn |
| Jan 31, 2023 | 31.60 Mn |
| Oct 31, 2022 | 29.10 Mn |
| Jul 31, 2022 | 28.70 Mn |
| Apr 30, 2022 | 26.30 Mn |
| Jan 31, 2022 | 26.20 Mn |
| Oct 31, 2021 | 25.70 Mn |
| Jul 31, 2021 | 24.80 Mn |